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Abstract
In this study, the draft genome sequences of two different carbapenem-resistant Acinetobacter baumannii clinical
strains isolated from the same blood culture sample of an Iranian patient were determined. The strain A. baumannii
554S harbouring blaoxa72 gene belonged to ST 307 whereas A. baumannii 554L carrying blaoxa23 gene belonged
to ST 2. We found that this sample contains two different isolates of A. baumannii, each phenotypically and
genetically different.
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Introduction
Acinetobacter baumannii is one of the most common
opportunistic Gram-negative bacterial pathogen causing
nosocomial infections. The worldwide emergence of
multidrug-resistant A. baumannii (MDR-AB), especially
carbapenem-resistant isolates, has been reported [1]. In
Iran, the prevalence of MDR-AB is currently high and
on the rise, resulting in increasing mortality and morbid-
ity rates among patients [2].
Case report
In this study, A. baumannii strains 554S and 554L were
isolated from the blood sample of a 10-year-old girl with
a burn injury who was hospitalized at Taleghani Burn
Hospital in Ahvaz, southwest Iran, on July 25, 2012. On
July 27, she became febrile, so a blood culture was real-
ized. Because of the delay between admission and positive
culture, we considered that the infection was hospital-
acquired. From July 27 to July 31, she was treated empiric-
ally with 20 mg of amikacin and 1 g of ceftazidime. Then,
on August 1, her antibiotic treatment was replaced
with 500 mg of meropenem and 2 g/250 mg of
piperacillin-tazobactam. From August 3 to August 11, this
treatment was replaced with 500,000 IU of colistin. Then,
the patient moved hospitals and sadly died on August 21,
2012. Thus, we believe that the patient eventually died
from the burn injury and not from the infection with these
bacteria. After the blood sample was plated on chocolate
agar, two different colonies with different morphological
aspects were observed: one small and one large colony
(Fig. 1). The two isolates were identified by MALDI-TOF
(matrix-assisted laser desorption/ionization time-of-flight
mass spectrometry; Microflex, Bruker Daltonics, Bremen,
Germany) as Acinetobacter baumannii strains. Antibiotic
susceptibility testing (AST) was performed by the disc dif-
fusion method and interpreted according to the European
Committee on Antimicrobial Susceptibility Testing guide-
lines (http://www.eucast.org/). The two isolates were re-
sistant to carbapenems but full AST revealed that the
strains do not have the same profile. The isolate 554L har-
boring blaOXA-23 was resistant to all antimicrobials tested
with the exception of tigecycline and colistin, whereas the
isolate 554S harboring blaOXA-72 was also susceptible to
doxycycline and tetracycline (Table 1).
Genomic DNA (gDNA) of A. baumannii strains 554S
and 554L were sequenced on a MiSeq sequencer (Illumina
Inc., San Diego, CA, USA) using the paired-end strategy.
Raw reads were assembled with A5-miseq software [3].
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Genomes annotation was performed by Rapid Annotation
using Subsystem Technology (RAST) [4]. tRNA gene
detection was performed using the tRNAScanSE 2.0 tool
[5], whereas ribosomal RNA genes were detected using
RNAmmer [6]. The sequence type (ST) of strains was
analyzed by the MLST 1.8 server of the Center for
Genetic Epidemiology. Antimicrobial resistance gene pro-
filing was performed in silico using ARG-ANNOT [7].
Further bioinformatic analysis, such as identification of
genomic islands, prophage sequences, clustered regularly
interspaced short palindromic repeat (CRISPR) sequences,
secondary metabolite gene clusters and plasmid presence
were predicted by employing IslandViewer, PHASTER,
CRISPRFinder, antiSMASH and Plasmid finder tools, re-
spectively. The percentage of similarity between strains
was calculated by pairwise comparison of their Average
Nucleotide Identity based on Blast (ANIb) by Jspecies
software [8].
The draft genome of 554S had 386 scaffolds that com-
prised 4,056,106 bp with a 39% G + C content. Similarly,
the 554L draft genome was composed of 580 scaffolds,
having a total size of 3,922,359 bp long with 39.1% G +
C content. The draft genomes of A. baumannii strains
554S and 554L contained 3884/3689 coding sequences,
8/8 rRNAs, 64/62 tRNAs, respectively. In silico MLST
analysis using the Pasteur Institute typing scheme re-
vealed that strains 554S and 554L belong to ST 307 and
ST 2, respectively. The strain 554S had 97.1% of similarity
with the strain 554L. ARG-ANNOT result analysis re-
vealed that the genomes of strains 554S and 554L encoded
12 and 16 antimicrobial resistance genes, respectively.
Genes that harbored resistance to beta-lactams (blaMBL,
blaA1, blaA2), aminoglycosides (armA, aphA6), macrolides
(mphE, msrE) and sulfamides (sul2) were detected in both
genomes. Moreover, in the 554S genome we found genes
blaADC-76, blaOXA-72, blaOXA-235, blaOXA-64, while the genes
blaADC-73, blaTEM-1D, blaOXA-23, blaOXA-66, aph3”Ia, strA,
strB and tetB were unique to the 554L genome (Table 1).
Both strains presented the disrupted ATPase encoding
comM gene. The genome of the isolate 554S contained at
least 28 genomics islands and one complete prophage se-
quence. Also, three CRISPR sequences could be predicted.
For the genome of the isolate 554L, 23 genomic islands
and one incomplete prophage sequence were found but no
CRISPR sequences. The presence of three putative second-
ary metabolite gene clusters, including arylpolyene, sidero-
phore and non-ribosomal peptide synthetase (NRPS) gene
clusters, could also be predicted in both genomes whereas
hserlactone-arylpolyene was predicted only in the 554L
genome. Neither strain carried a plasmid.
Discussion
In summary, we reported the draft genome sequences of
two clinical MDR-AB strains in Iran. A. baumannii is
known with its high resistance to carbapenems worldwide
[1, 9]. In a national Iranian study, the mean prevalence of
MDR-AB was 71% during the period 2010–2015 [2]. In
the Taleghani Burn Hospital of our study, this prevalence
increased with 92.5% of A. baumannii carbapenem
Fig. 1 Isolation of A. baumannii strains 554S and 554L on Mac Conkey
plate: strain 554S on left and strain 554L on right
Table 1 Characteristics of A. baumannii strains 554S and 554L analyzed in this study
Strains ST Size (bp) GC% Genomic features Susceptible AST
phenotype
Resistant AST phenotype Resistant genes Genbank accession
number
554S 307 4,056,106 39 3884 CDS,8
rRNAs, 64tRNAs
TIG, CT,
DOX, TET
AMX, AMC, TCC, FOX, CTX,
CRO, IMP, ETP, CIP, AZT, AK,
TOB, GEN, RA, SXT
blaMBL, blaA1, blaA2, blaADC-76,
blaOXA-72, blaOXA-235, blaOXA-64,
armA, aphA6, mphE, msrE, sul2
NKXP00000000
554L 2 3,922,359 39.1 3689 CDS,8
rRNAs, 62 tRNAs
TIG, CT AMX, AMC, TCC, FOX, CTX,
CRO, IMP, ETP, CIP, AZT, AK,
TOB, GEN, RA, SXT, DOX, TET
blaMBL, blaA1, blaA2, blaADC-73,
blaTEM-1D, blaOXA-23, blaOXA-66,
armA, aph3”, Ia, aphA6, mphE,
msrE, sul2, str A, strB, tetB
NKXQ00000000
CDS: Coding DNA Sequence, AMX: Amoxicillin, AMC: Amoxicillin/clavulanic acid, TCC: Ticarcillin/clavulanic acid, FOX: Cefoxitin, CTX: Cefotaxime, CRO: Ceftriaxone,
IMP: Imipenem, ETP: Ertapenem, CIP: Ciprofloxacin, AZT: Aztreonam, AK: Amikacin, TOB: Tobramycin, GEN: Gentamycin, RA: Rifampicin, SXT: Sulfamethoxazole/
trimethoprim, DOX: Doxycycline, TET: Tetracyclin, TIG: Tigecycline, CT: Colistin
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resistant [10]. Carbapenem resistance in A. baumannii
was principally due to the production of oxacillinases in-
cluding OXA-23, OXA-24, OXA-58 enzymes, and the
New Delhi Metallo-β-lactamase 1 (NDM-1) [1]. OXA-23
enzymes were predominant among MDR-AB in several re-
gions worldwide [9]. The international clone II corre-
sponding to ST 2 of the Pasteur MLST scheme was
associated with nosocomial outbreaks and had spread glo-
bally [9, 11]. As with Europe, the spread of MDR-AB clo-
nage lineage II producing blaoxa23-like and blaoxa24-like
was described in Iran [12]. Our results confirmed these
studies with the description of one MDR-AB strain 554L
carrying blaoxa23 gene belonging to ST 2 and the second
strain 554S harbouring blaoxa72 (blaoxa24-like) gene belong-
ing to ST 307. Although isolated from the same blood cul-
ture sample, these two strains were phenotypically and
genetically different. The different ST and the weak per-
centage of similarity between these strains confirmed that
we had two different clones of A. baumannii in the same
sample. These isolates were resistant to several antibiotics
and only tigecycline and colistin were effective on both
strains. Each strain carried different resistance genes, with
the blaOXA-72 encoding carbapenem resistance gene found
in the isolate 554S and the blaOXA-23 gene present in the
strain 554L. The co-occurrence of different carbapene-
mase genes in the same Acinetobacter strain has already
been described [13]. However, few genome sequence ana-
lyses explain this phenomenon. We could observe one car-
bapenemase encoding gene in a chromosome and one in a
plasmid [14], or both in a chromosome [13]. In our case,
without a careful observation of the colonies’ morpho-
logical aspect, we might conclude the presence of one
strain of A. baumannii harboring two carbapenemases
genes (blaOXA-23 and blaOXA-72), whereas we had two dif-
ferent A. baumannii strains, each harboring one carbape-
nemase gene. Hence, this study has revealed the
possibility that double carbapenemase producers previ-
ously reported in the literature could in fact be a dual
infection. Further work is warranted to understand if
this phenomenon is common in human infections.
These data also revealed molecular mechanisms con-
tributing to bacterial drug resistance dissemination and
expanded our understanding of the genomic features of
MDR-AB in Iran. To our knowledge, this was the first
draft genome sequences of MDR-AB isolates in Iran.
These Whole Genome Shotgun projects have been de-
posited in DDBJ/EMBL/GenBank under the sequence ac-
cession numbers NKXP00000000 and NKXQ00000000
for strains 554S and 554L, respectively.
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